Results 101 to 110 of about 31,000 (231)

Thrombotic thrombocytopenic purpura mimicking an acute meningoencephalitis

open access: yes, 2011
Thrombotic thrombocytopenic purpura is a rare, life-threatening disease characterized by thrombocytopenia, microangiopathic haemolytic anaemia and organ dysfunction, e.g. neurological impairment and renal insufficiency.
Felicani C   +8 more
core   +2 more sources

ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission

open access: yesHaematologica, 2008
Background From 20 to 50% of patients who survive an acute episode of the acquired form of thrombotic thrombocytopenic purpura relapse but clinical and laboratory markers of recurrence are not well established.Design and Methods In 109 patients enrolled ...
Flora Peyvandi   +15 more
doaj   +1 more source

Maternal–fetal platelet alloimmunization: Identification of risk factors for severe neonatal thrombocytopenia

open access: yesTransfusion, Volume 66, Issue 7, Page 1316-1325, July 2026.
Abstract Background Feto‐maternal platelet alloimmunization (FNAIT) is a rare condition (1 in 1500 live pregnancies), most commonly diagnosed based on clinical neonatal hemorrhagic manifestations, which can vary in severity. The aim of our study was to identify risk factors for severe fetal/neonatal thrombocytopenia in cases of FNAIT.
Elise Deroubaix   +7 more
wiley   +1 more source

A case of thrombotic thrombocytopenic purpura induced by acute pancreatitis

open access: yes, 2012
Miyoko Arimoto1, Yutaka Komiyama2, Fumiko Okamae1, Akemi Ichibe1, Setsuko Teranishi1, Hirohiko Tokunaga1, Keiko Nakaya3, Michie Fujiwara3, Manabu Yamaoka4, Shuji Onishi4, Rie Miyamoto5, Naoto Nakamichi5, Shosaku Nomura51Blood Transfusion Unit, Kansai ...
Onishi S   +12 more
core  

Pembrolizumab-induced thrombotic thrombocytopenic purpura

open access: yes, 2019
Introduction Pembrolizumab is a humanised monoclonal antibody targeting the receptor programmed cell death protein-1 (PD-1), with anti-tumour activity demonstrated for many malignancies.
Collins, Joel T.   +6 more
core   +1 more source

Recombinant ADAMTS13 for Hereditary Thrombotic Thrombocytopenic Purpura.

open access: yes, 2022
A 27-year-old patient with a history of severe obstetrical complications and arterial thrombosis received a diagnosis of hereditary thrombotic thrombocytopenic purpura (TTP) due to severe ADAMTS13 deficiency when she presented with an acute episode in ...
Ganter, Michael T   +9 more
core   +1 more source

Long-term Kidney Outcomes in Patients With Acquired Thrombotic Thrombocytopenic Purpura

open access: yesKidney International Reports, 2017
Severe acute kidney injury (AKI) and chronic kidney disease (CKD) are considered to be uncommon in patients with acquired thrombotic thrombocytopenic purpura.
Dustin J. Little   +5 more
doaj   +1 more source

Esplenectomiavídeo-laparoscópica [PDF]

open access: yes, 1998
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Departamento de Clínica Médica, Curso de Medicina, Florianópolis ...
Onzi, Tiago Rafael
core  

Generalized sarcoidosis and severe thrombocytopenic purpura: clinical observation and literature review

open access: yes, 2020
Sarcoidosis is a disease of an unknown etiology and is characterized by a wide range of clinical manifestations due to granulomatous damage of the lungs and other organs.
A.B. Ponomarev   +4 more
core   +1 more source

The need for dried plasma—Still a national issue: Where are we and recommendations

open access: yes
Transfusion, EarlyView.
Anthony E. Pusateri   +24 more
wiley   +1 more source

Home - About - Disclaimer - Privacy